ロード中...
Combining selective inhibitors of nuclear export (SINEs) with chimeric antigen receptor (CAR) T cells for CD19-positive malignancies
Chimeric antigen receptor (CAR) T cells directed against CD19 (CD19.CAR T cells) have yielded impressive clinical responses in the treatment of patients with lymphoid malignancies. However, resistance and/or relapse can limit treatment outcome. Risk of tumor escape can be reduced by combining treatm...
保存先:
| 出版年: | Oncol Rep |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
D.A. Spandidos
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8250584/ https://ncbi.nlm.nih.gov/pubmed/34165175 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2021.8121 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|